ZEGA Investments LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 2,229 shares of the medical equipment provider's stock, valued at approximately $1,163,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last ninety days. Company insiders own 0.90% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on ISRG shares. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 18th. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $611.86.
Get Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Price Performance
ISRG traded down $10.78 during trading on Wednesday, reaching $509.03. The company had a trading volume of 1,979,293 shares, compared to its average volume of 1,463,547. The company has a market cap of $181.31 billion, a P/E ratio of 79.41, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business's fifty day moving average price is $561.24 and its 200 day moving average price is $532.59.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.